Alabama SJR60 encourages the Alabama Medicaid Agency to evaluate the costs of GLP-1 medications and report findings.
Alabama SJR60 urges the Alabama Medicaid Agency to assess the overall costs of GLP-1 medications for weight management and report its findings to the Legislature before the 2027 session. The resolution highlights the potential savings and health benefits of these medications, considering the high prevalence of obesity in Alabama and its economic impact. The Agency is also tasked with evaluating potential savings from new drug pricing models and continuing discussions with providers and stakeholders to optimize health outcomes and cost savings.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.